Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | +3.23% | +3.90% | -18.78% |
04-29 | Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem | CI |
03-28 | Transcript : Iterum Therapeutics plc, Q4 2023 Earnings Call, Mar 28, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.78% | 25.66M | |
+22.01% | 47.9B | |
+46.56% | 41.42B | |
-2.15% | 40.7B | |
-6.20% | 28.92B | |
+10.33% | 25.55B | |
-21.14% | 19.27B | |
-2.07% | 12.15B | |
+31.68% | 12.14B | |
-0.33% | 11.99B |
- Stock Market
- Equities
- ITRM Stock
- News Iterum Therapeutics plc
- Iterum Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2021